RALEIGH, N.C. – Consigli Construction Co., Inc. has named William Royall, P.E., Director of Pharmaceutical Manufacturing. Royall brings more than 30 years of experience and has delivered more than $2 billion in life sciences and biopharmaceutical facilities along the East Coast. He will lead the growth of Consigli’s pharmaceutical manufacturing portfolio and client relationships across the life sciences industry.

Royall’s experience spans the full project lifecycle, from planning and design through construction, commissioning, qualification and validation (CQV) and turnover. He has led major programs for global biopharmaceutical companies including Bristol Myers Squibb, Merck & Co., GSK, DSM Pharmaceuticals, Pfizer and Novo Nordisk.

“As more manufacturing comes back to the U.S., and especially here in North Carolina, owners need builders who understand the process as well as the building,” said Todd McCabe, Executive Vice President. “Will’s experience delivering complex cGMP facilities from design through validation gives our life sciences team that perspective,as well as strengthens our ability to help clients bring new capacity online with confidence.”

Throughout his career, Royall has led multidisciplinary teams and supported strategies designed to accelerate project delivery and bring manufacturing facilities online efficiently, and has significant technical expertise in regulatory, utility and processing requirements. His experience also includes large-scale greenfield developments, such as the EPC/M delivery of a $900 million greenfield liquid production facility within Novo Nordisk’s $4 billion, 1.4 million sq. ft. fill-and-finish campus in Clayton, North Carolina, as well as management of complex projects within active manufacturing environments requiring careful coordination with ongoing operations.

Learn more about Consigli’s work in the life sciences market here.